Overview

Antibiotic Safety (SCAMP)

Status:
Completed
Trial end date:
2017-04-20
Target enrollment:
Participant gender:
Summary
The main purpose of this study is evaluate whether it is safe or not to use various combination of antibiotics (ampicillin, metronidazole, clindamycin, piperacillin-tazobactam, gentamicin) in treating infants with complicated intra-abdominal infections
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Michael Cohen-Wolkowiez
Collaborators:
The Emmes Company, LLC
The EMMES Corporation
Treatments:
Ampicillin
Anti-Bacterial Agents
Antibiotics, Antitubercular
Clindamycin
Clindamycin palmitate
Clindamycin phosphate
Gentamicins
Metronidazole
Penicillanic Acid
Piperacillin
Piperacillin, Tazobactam Drug Combination
Tazobactam